NEW YORK (Reuters Health) – A novel, non-culture-based assay called the ribosomal RNA synthesis (RS) ratio provides a molecular metric to assess the effects of
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
